XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS
9 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

NOTE 3. COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS


Inventory


Inventory is stated at the lower of cost (first-in, first-out) or net realizable value and consists of the following (in thousands):


 

 

March 31,
2019

 

 

June 30,
2018

 

Raw materials /purchased components

 

$

2,099

 

 

$

1,878

 

Work in process

 

 

1,431

 

 

 

974

 

Sub-assemblies /finished components

 

 

1,157

 

 

 

1,193

 

Finished goods

 

 

118

 

 

 

348

 

Total inventory

 

$

4,805

 

 

$

4,393

 

 

Investments


Investments are stated at market value and consist of the following (in thousands):


 

 

March 31,
2019

 

 

June 30,
2018

 

Marketable equity securities – short-term

 

$

2,814

 

 

$

2,220

 

Marketable equity securities – long-term

 

 

234

 

 

 

 

Total Marketable equity securities

 

$

3,048

 

 

$

2,220

 

 

Investments at March 31, 2019 and June 30, 2018 had an aggregate cost basis of $3,364,000 and $2,373,000, respectively. The long-term investments include an equity security purchased during the third quarter of fiscal 2019 that is thinly traded and therefore we classified the asset as long term in nature because even if we decide to sell the stock we may not be able to sell our position within one year. At March 31, 2019, the investments included gross unrealized losses of $316,000 and no unrealized gains. At June 30, 2018, the investments included net unrealized losses of $153,000 (gross unrealized losses of $196,000 offset by gross unrealized gains of $43,000).


Of the total short-term marketable equity securities at March 31, 2019 and June 30, 2018, $997,000 and $285,000, respectively, represent an investment in the common stock of Air T, Inc. Two of our Board members are also board members of Air T, Inc. and both either individually or through affiliates own an equity interest in Air T, Inc. Our Chairman, one of the two Board members aforementioned, also serves as the Chief Executive Officer and Chairman of Air T, Inc. The shares have been purchased through 10b5-1 Plans, which in accordance with our internal policies regarding the approval of related party transactions, was approved by our three Board members that are not affiliated with Air T, Inc.


We invest surplus cash from time to time through our Investment Committee, which is comprised of one management director, Mr. Van Kirk, and two non-management directors, Mr. Cabillot and Mr. Swenson, who chairs the committee. Both Mr. Cabillot and Mr. Swenson are active investors with extensive portfolio management expertise. We leverage the experience of these committee members to make investment decisions for the investment of our surplus operating capital or borrowed funds. Additionally, many of our securities holdings include stocks of public companies that either Messrs. Swenson or Cabillot or both may own from time to time either individually or through the investment funds that they manage, or other companies whose boards they sit on, such as Air T, Inc.


Intangibles


Intangibles consist of the following (in thousands):

 

 

 

March 31,
2019

 

 

June 30,
2018

 

Covenant not to compete

 

 

 

 

 

30

 

Patent-related costs

 

 

175

 

 

 

164

 

Total intangibles

 

$

175

 

 

$

194

 

Less accumulated amortization

 

 

(42

)

 

 

(54

)

 

 

$

133

 

 

$

140

 


The covenant not to compete relates to assets acquired in conjunction with a business acquisition. The covenant not to compete and related accumulated amortization were retired during the second quarter of fiscal 2019. Patent-related costs consist of legal fees incurred in connection with both patent applications and a patent issuance, and will be amortized over the estimated life of the product(s) that is or will be utilizing the technology, or expensed immediately in the event the patent office denies the issuance of the patent. Since we do not know when, or if, our patent applications will be issued, the future amortization expense is not predictable.